Floatz logo

Esmolol

Post-Operative Pain, Non-Human Animal

Ain Shams UniversitySmall moleculePhase 4 / ApprovedDormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
81/ 100

Competitive context

23 Active assets in the Post-Operative Pain, Non-Human Animal cohort.

Asset / SponsorPhaseRating
Lidocaine
Instituto Mexicano del Seguro Social
Phase 4BBB
Ropivacaine
Tianjin Medical University General Hospital
Phase 4BBB
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Tanta University
Phase 4BBB
Nepenthe
IVO JURISIC
Phase 4BBB
Fentanyl
IVO JURISIC
Phase 4BB

View all 38 →

Same molecule, other indications

Esmolol is also rated in:

hemorrhagic strokeDormant
BB
Indicative · Phase 4
65 / 100
View asset →
diabetes mellitusActive
B
Indicative · Phase 3
60 / 100
View asset →
neoplasmActive
B
Indicative · Phase 3
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →